WO2003068150A3 - Methods of treating and diagnosing arthritis - Google Patents
Methods of treating and diagnosing arthritis Download PDFInfo
- Publication number
- WO2003068150A3 WO2003068150A3 PCT/US2003/003708 US0303708W WO03068150A3 WO 2003068150 A3 WO2003068150 A3 WO 2003068150A3 US 0303708 W US0303708 W US 0303708W WO 03068150 A3 WO03068150 A3 WO 03068150A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treating
- methods
- diagnosing arthritis
- diagnosing
- arthritis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0325—Animal model for autoimmune diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003209049A AU2003209049A1 (en) | 2002-02-11 | 2003-02-06 | Methods of treating and diagnosing arthritis |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35604102P | 2002-02-11 | 2002-02-11 | |
US60/356,041 | 2002-02-11 | ||
US35777502P | 2002-02-19 | 2002-02-19 | |
US60/357,775 | 2002-02-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003068150A2 WO2003068150A2 (en) | 2003-08-21 |
WO2003068150A3 true WO2003068150A3 (en) | 2004-01-08 |
Family
ID=27737514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/003708 WO2003068150A2 (en) | 2002-02-11 | 2003-02-06 | Methods of treating and diagnosing arthritis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003209049A1 (en) |
WO (1) | WO2003068150A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007095154A2 (en) | 2006-02-10 | 2007-08-23 | The Brigham And Women's Hospital, Inc. | Lectin complement pathway assays and related compositions and methods |
AU2008214359B2 (en) * | 2007-02-05 | 2014-01-16 | Apellis Pharmaceuticals, Inc. | Local complement inhibition for treatment of complement-mediated disorders |
WO2014151923A1 (en) * | 2013-03-14 | 2014-09-25 | Baxter International Inc. | Factor h for treatment of rheumatoid arthritis |
JP7156827B2 (en) * | 2018-06-08 | 2022-10-19 | デンカ株式会社 | Reagent for measuring complement titer and method for stabilizing measured value of complement titer using the same |
EP3771468A1 (en) * | 2019-07-31 | 2021-02-03 | Universitätsklinikum Hamburg-Eppendorf | C3/c5 convertase assays |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001053824A1 (en) * | 2000-01-18 | 2001-07-26 | The General Hospital Corporation | Mouse model for rheumatoid arthritis |
US6319897B1 (en) * | 1996-03-13 | 2001-11-20 | John D. Lambris | Peptides which inhibit complement activation |
US20020081293A1 (en) * | 1998-02-20 | 2002-06-27 | Tanox, Inc., Delaware Corporation | Inhibitors of complement activation |
-
2003
- 2003-02-06 AU AU2003209049A patent/AU2003209049A1/en not_active Abandoned
- 2003-02-06 WO PCT/US2003/003708 patent/WO2003068150A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319897B1 (en) * | 1996-03-13 | 2001-11-20 | John D. Lambris | Peptides which inhibit complement activation |
US20020081293A1 (en) * | 1998-02-20 | 2002-06-27 | Tanox, Inc., Delaware Corporation | Inhibitors of complement activation |
WO2001053824A1 (en) * | 2000-01-18 | 2001-07-26 | The General Hospital Corporation | Mouse model for rheumatoid arthritis |
Non-Patent Citations (3)
Title |
---|
JI H. ET AL.: "Arthritis critically dependent on innate immune system players", IMMUNITY, vol. 16, February 2002 (2002-02-01), pages 157 - 168, XP002968950 * |
MCGRATH Y. ET AL.: "Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseases", J. IMMUNOL., vol. 163, 1999, pages 6834 - 6840, XP002968951 * |
YOSHIDA K. ET AL.: "An immunochemical method for assessing the function of the alternative complement pathway", INT. ARCHS. ALLERGY APPL. IMMUN., vol. 75, 1984, pages 173 - 178 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003068150A2 (en) | 2003-08-21 |
AU2003209049A8 (en) | 2003-09-04 |
AU2003209049A1 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005000897A3 (en) | Antibodies against interleukin-22 and uses therefor | |
DE69915482D1 (en) | CLUTCH FOR AN EXCAVATOR TOOTH OR THE LIKE | |
PL1608250T3 (en) | A combination, comprising a compartment, a closure, and at least one fasterner, the combination forming an array with other combinations | |
WO2004081026A3 (en) | Polypeptides | |
WO2005076957A3 (en) | Cost sensitivity decision tool for predicting and/or guiding health care decisions | |
WO2005040229A3 (en) | Ldl receptor class a and egf domain monomers and multimers | |
WO2003077630A3 (en) | Method and apparatus for synthesis | |
ATE515287T1 (en) | DYNAMIC TELEMETRY CONNECTION SELECTION FOR AN IMPLANTABLE DEVICE | |
WO2006113305A3 (en) | System and method for providing a waveform for stimulating biological tissue | |
WO2005084240A3 (en) | Method and system for providing links to resources related to a specified resource | |
HK1121879A1 (en) | Method and apparatus for determining scrambling codes for signal transmission | |
WO2005101834A3 (en) | Methods and apparatuses for mapping locations | |
GB0511307D0 (en) | A method for generating output data | |
AU5288599A (en) | Disubstituted bicyclic heterocycles having, in particular, thrombin inhibitiveeffect | |
WO2004098326A3 (en) | Garments and methods of manufacturing | |
ZA200307103B (en) | Variable exception reporting. | |
WO2003093433A3 (en) | Fibrin-based biomatrix | |
ID23444A (en) | POLYURETHAN LATEXS, PROCESSES FOR MAKING IT AND THE POLYMERS CREATED WITH IT | |
CA2471285A1 (en) | Method for producing an impact-resistant polymethylmethacrylate, and corresponding polymethylmethacrylate (pmma) | |
WO2001038352A3 (en) | Methods of inhibiting metastasis | |
WO2003068150A3 (en) | Methods of treating and diagnosing arthritis | |
WO2003083077A3 (en) | Antibody libraries | |
WO2004036366A3 (en) | Load testing methods and systems with transaction variability andconsistency | |
BRPI0417494A (en) | friction material | |
WO2003047422A3 (en) | Device and method using integrated neuronal cells and an electronic device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |